Handok, AEterna Zentaris sign licensing agreement over oral anti-cancer agent

Handok Pharm announced on April 23 announced the signing of a licensing agreement with Canada based AEterna Zentaris Inc. to distribute Perifosine in Korea, a novel, potentially first-in-class, oral anti-cancer agent that was developed by AEterna Zentaris.

Æterna Zentaris is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, ...